Duration of Prophylaxis against Venous Thromboembolism with Low Molecular Weight heparin (Enoxaparin Sodium) after Major Abdominal Surgery.

Trial Profile

Duration of Prophylaxis against Venous Thromboembolism with Low Molecular Weight heparin (Enoxaparin Sodium) after Major Abdominal Surgery.

Completed
Phase of Trial: Phase III

Latest Information Update: 13 May 2016

At a glance

  • Drugs Enoxaparin sodium (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top